Auswahl der wissenschaftlichen Literatur zum Thema „Hemolytic uremic syndrome Prevention“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Hemolytic uremic syndrome Prevention" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Hemolytic uremic syndrome Prevention":
Yoshiya, Kunihiko, Kouichi Nakanishi, Seiko Itoh, Kazumoto Iijima, Norishige Yoshikawa, Hajime Nakamura, Tae Takeda und Kazuhiro Kobayashi. „Etiology and prevention of hemolytic uremic syndrome“. Nihon Shoni Jinzobyo Gakkai Zasshi 7, Nr. 2 (1994): 161–63. http://dx.doi.org/10.3165/jjpn.7.161.
Afshar-Kharghan, Vahid. „Atypical hemolytic uremic syndrome“. Hematology 2016, Nr. 1 (02.12.2016): 217–25. http://dx.doi.org/10.1182/asheducation-2016.1.217.
Goldwater, Paul N. „Treatment and prevention of enterohemorrhagicEscherichia coliinfection and hemolytic uremic syndrome“. Expert Review of Anti-infective Therapy 5, Nr. 4 (August 2007): 653–63. http://dx.doi.org/10.1586/14787210.5.4.653.
Haslam, David B. „Molecular Decoys: Novel Approaches to the Prevention of Hemolytic Uremic Syndrome“. Pediatric Research 48, Nr. 3 (September 2000): 267–68. http://dx.doi.org/10.1203/00006450-200009000-00001.
Joseph, Adrien, Aurélie Cointe, Patricia Mariani Kurkdjian, Cédric Rafat und Alexandre Hertig. „Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review“. Toxins 12, Nr. 2 (21.01.2020): 67. http://dx.doi.org/10.3390/toxins12020067.
TARR, PHILLIP I. „Escherichia coli O157: H7: Overview of Clinical and Epidemiological Issues“. Journal of Food Protection 57, Nr. 7 (01.07.1994): 632–37. http://dx.doi.org/10.4315/0362-028x-57.7.632.
Davin, Jean-Claude, Charles Majoie, Jaap Groothoff, Valentina Gracchi, Antonia Bouts, Timothy H. J. Goodship und Chantal Loirat. „Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulation“. Pediatric Nephrology 26, Nr. 1 (24.07.2010): 155–57. http://dx.doi.org/10.1007/s00467-010-1608-9.
Nuernberger, Jens, Oliver Witzke, Russell P. Rother, Thomas Philipp, Udo Vester, Hideo Baba, Lothar Bernd Zimmerhackl und Andreas Kribben. „Successful Treatment of Atypical Hemolytic Uremic Syndrome with the Complement Inhibitor Eculizumab.“ Blood 112, Nr. 11 (16.11.2008): 2294. http://dx.doi.org/10.1182/blood.v112.11.2294.2294.
Noris, Marina, und Giuseppe Remuzzi. „Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation“. Current Opinion in Nephrology and Hypertension 22, Nr. 6 (November 2013): 704–12. http://dx.doi.org/10.1097/mnh.0b013e328365b3fe.
Avila Bernabeu, Ana Isabel, Teresa Cavero Escribano und Mercedes Cao Vilarino. „Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era“. Nephron 144, Nr. 11 (2020): 537–49. http://dx.doi.org/10.1159/000508920.
Dissertationen zum Thema "Hemolytic uremic syndrome Prevention":
Srimanote, Potjanee. „Analysis of putative virulence factors of a locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli O113:H21 strain“. Title page, contents and abstract only, 2003. http://web4.library.adelaide.edu.au/theses/09PH/09php863.pdf.
Noris, Marina. „Genetics of hemolytic uremic syndrome“. Maastricht : Maastricht : Universiteit Maastricht ; University Library, Maastricht University [Host], 2006. http://arno.unimaas.nl/show.cgi?fid=7591.
Maga, Tara Kristen. „Unraveling the complex genetics of atypical hemolytic uremic syndrome“. Diss., University of Iowa, 2012. https://ir.uiowa.edu/etd/2935.
Edwards, Kelly Katherine. „Bacterial factors contributing to the pathogenesis of the hemolytic uremic syndrome“. MU has:, 2002. http://wwwlib.umi.com/cr/mo/fullcit?p3060096.
Bu, Fengxiao. „Exploring the genetics of a complex disease - atypical hemolytic uremic syndrome“. Diss., University of Iowa, 2016. https://ir.uiowa.edu/etd/3055.
Karpman, Diana O. „Studies of the pathogenesis of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura“. Lund : Lund University, 1997. http://catalog.hathitrust.org/api/volumes/oclc/68945090.html.
Valoti, Elisabetta. „Genetic factors associated with anti-factor H autoantibodies in atypical hemolytic uremic syndrome (aHUS)“. Thesis, Open University, 2018. http://oro.open.ac.uk/55853/.
Morigi, Marina. „Unravelling molecular and biochemical dysfunction by Shiga toxin: implication for thrombotic microangiopathy in Hemolytic Uremic Syndrome“. Maastricht : Maastricht : Universiteit Maastricht ; University Library, Maastricht University [Host], 2006. http://arno.unimaas.nl/show.cgi?fid=7590.
Marinozzi, Maria Chiara. „Characterization of the complement hereditary and acquired abnormalities in atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy“. Thesis, Sorbonne Paris Cité, 2016. http://www.theses.fr/2016USPCB037/document.
McGannon, Colleen M. „Antibiotic Therapy in the Treatment of E. coli O157:H7“. University of Cincinnati / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1230919332.
Bücher zum Thema "Hemolytic uremic syndrome Prevention":
Parker, James N., und Philip M. Parker. The official patient's sourcebook on hemolytic uremic syndrome. Herausgegeben von Icon Group International Inc und NetLibrary Inc. San Diego, Calif: Icon Health Publications, 2002.
Rotman, Tamara Avril. Role of verocytotoxin-1 in the pathogenesis of hemorrhagic colitis and hemolytic uremic syndrome. Ottawa: National Library of Canada, 1992.
1941-, Kaplan Bernard S., Trompeter Richard S und Moake Joel L. 1940-, Hrsg. Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. New York: Marcel Dekker, Inc., 1992.
Clayton, Glenna. Hemolytic Uremic Syndrome: Symptoms, Treatment Options and Prognosis. Nova Science Publishers, Incorporated, 2014.
Globotriaosylceramide (Gb3) expression and membrane presentation: Implications for the hemolytic uremic syndrome and human immunodeficiency virus infection. Ottawa: National Library of Canada, 2003.
Publications, ICON Health. The Official Patient's Sourcebook on Hemolytic Uremic Syndrome: A Revised and Updated Directory for the Internet Age. Icon Health Publications, 2002.
Enterohemorrhagic Escherichia coli and Other Shiga Toxin-Producing E. coli. ASM Press, 2015.
F, Zipfel Peter, Hrsg. Complement and kidney disease. Basel: Birkhäuser, 2005.
Escherichia coli O157:H7 and other shiga toxin-producing E. coli strains. Washington, DC: ASM Press, 1998.
Buchteile zum Thema "Hemolytic uremic syndrome Prevention":
Sethi, Sidharth Kumar. „Hemolytic Uremic Syndrome“. In Critical Care Pediatric Nephrology and Dialysis: A Practical Handbook, 187–94. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-2276-1_15.
Ali, Uma, und Bradley P. Dixon. „Hemolytic Uremic Syndrome“. In Critical Care Nephrology and Renal Replacement Therapy in Children, 129–44. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-90281-4_9.
Metze, Dieter, Vanessa F. Cury, Ricardo S. Gomez, Luiz Marco, Dror Robinson, Eitan Melamed, Alexander K. C. Leung et al. „Hemolytic Uremic Syndrome“. In Encyclopedia of Molecular Mechanisms of Disease, 801–2. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_763.
Clark, Elaine, und Scott Orme. „Hemolytic-uremic syndrome.“ In Health-related disorders in children and adolescents: A guidebook for understanding and educating., 309–14. Washington: American Psychological Association, 1998. http://dx.doi.org/10.1037/10300-042.
Eddins, Michelle McCown. „Hemolytic-Uremic Syndrome“. In Consults in Obstetric Anesthesiology, 255–56. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-59680-8_73.
Sethna, Christine B., und Shari Gurusinghe. „Hemolytic Uremic Syndrome“. In Glomerulonephritis, 1–19. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-27334-1_42-1.
Vercellone, Antonio, Piero Stratta und Caterine Canavese. „Hemolytic Uremic Syndrome“. In Advances in Experimental Medicine and Biology, 185–98. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4684-8240-9_24.
Sethna, Christine B., und Shari Gurusinghe. „Hemolytic Uremic Syndrome“. In Glomerulonephritis, 647–65. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-49379-4_42.
Johnson, S., und C. Mark Taylor. „Hemolytic Uremic Syndrome“. In Pediatric Nephrology, 1155–80. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-76341-3_48.
Watkins, Sandra L. „Hemolytic Uremic Syndrome“. In Textbook of Clinical Pediatrics, 2769–72. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-02202-9_297.
Konferenzberichte zum Thema "Hemolytic uremic syndrome Prevention":
Bahlavouni, Alina, und Aleena Paul. „Hemolytic Uremic Syndrome Associated with Entamoeba Histolytica“. In AAP National Conference & Exhibition Meeting Abstracts. American Academy of Pediatrics, 2021. http://dx.doi.org/10.1542/peds.147.3_meetingabstract.866.
Selvam, M. Masilamani, Divya Sasitharan und W. Manohar Paul. „Clinical validation of vaccines against hemolytic uremic syndrome“. In 2014 International Conference on Science Engineering and Management Research (ICSEMR). IEEE, 2014. http://dx.doi.org/10.1109/icsemr.2014.7043626.
Pankratenko, T. E., O. V. Moskalec und T. Yu Abaseeva T. „Cell adhesion molecules in childrenwith diarrhea-associated hemolytic uremic syndrome“. In General question of world science. "Л-Журнал", 2018. http://dx.doi.org/10.18411/gq-31-03-2018-13.
Moskalec, O. V., T. E. Pankratenko und T. Yu Abaseeva. „Soluble adhesion molecules in children with typical hemolytic uremic syndrome“. In Scientific achievements of the third millennium. SPC "LJournal", 2018. http://dx.doi.org/10.18411/scc-05-2018-06.
Abdou, M., M. Alsharif, T. Naguib und M. L. Patel. „Eculizumab: A Life Saver in Postpartum Atypical Hemolytic Uremic Syndrome“. In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6530.
ROMERO LEGRO, IVAN, Sadia Shah und Vaidehi Kaza. „Tacrolimus Induced Hemolytic Uremic Syndrome In A Lung Transplant Patient“. In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a5834.
Moskalets, O. V., T. E. Pankratenko und T. Yu Abaseeva. „Biomarkers of endothelial disfunction in children with atypical hemolytic uremic syndrome“. In Scientific achievements of the third millennium. SPC "LJournal", 2018. http://dx.doi.org/10.18411/scc-09-2018-08.
Cruz, Pedro Costa e., Patrícia Mendes, Marisol Anselmo und Luís Gonçalves. „P102 Typical vs atypical hemolytic-uremic syndrome: eculizumab, a difficult decision“. In 8th Europaediatrics Congress jointly held with, The 13th National Congress of Romanian Pediatrics Society, 7–10 June 2017, Palace of Parliament, Romania, Paediatrics building bridges across Europe. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2017. http://dx.doi.org/10.1136/archdischild-2017-313273.190.
Moskalets, O. V. „Prognostic value of sICAM-1 and sVCAM-1 in hemolytic uremic syndrome“. In Global science. Development and novelty. НИЦ «Л-Журнал», 2018. http://dx.doi.org/10.18411/gdsn-25-12-2018-04.
Pankratenko, T. E., und O. V. Moskalec. „sICAM-1 and sVCAM-1 in children with typical hemolytic uremic syndrome“. In Global science. Development and novelty. НИЦ «Л-Журнал», 2018. http://dx.doi.org/10.18411/gdsn-28-02-2018-07.